Sunday, March 13, 2011

FDA Grants Monopoly Over Preterm Labor Prevention Drug: 15,000 Percent Price Increase Then Announced

Still think the US Food and Drug Administration (FDA) has your best interests in mind? According to new reports, the agency has arbitrarily decided to grant exclusive approval to KV Pharmaceutical to produce the one-and-only FDA-approved premature birth prevention drug -- which is really just a modified, patented version of the common hormone progesterone -- administered to women with a high risk of preterm delivery. So what used to cost women as little as $10 to buy from their local compounding pharmacy will now cost $1,500, thanks to the FDA.'


No comments:

Post a Comment

Thanks for your comment it is much appreciated.